TY - JOUR T1 - Complete blood count with differential: An effective diagnostic for IBS subtype in the context of BMI? JF - bioRxiv DO - 10.1101/608208 SP - 608208 AU - JM Robinson AU - CM Boulineaux AU - KR Butler AU - PV Joseph AU - MT Murray AU - SN Pocock AU - LB Sherwin AU - SC Turkington AU - KR Weaver AU - WA Henderson Y1 - 2019/01/01 UR - http://biorxiv.org/content/early/2019/04/18/608208.abstract N2 - The Complete Blood Count with Differential hematological assay is a mainstay diagnostic for point-of-care clinical diagnoses for a spectrum of diseases including infection, inflammation, anemia, and leukemia, and CBC-D profiles are under investigation as early prognostic biomarkers for leukemias and other diseases. Chronic abdominal pain (CAP) and irritable bowel syndrome (IBS) are prevalent gastrointestinal disorders in the United States, with obesity among the most common comorbidities. Often, IBS-like gastrointestinal (GI) symptoms persist after resolution of known inflammation and/or enteropathogenic infection, and current literature contains significant discussion of the extent to which IBS is within the biological spectrum of inflammatory disease. Obesity is also associated with generalized signatures of inflammation and may confound accurate diagnoses. We performed ANOVA, multiple means comparisons, statistical analyses of CBC data from our "Brain-Gut Natural History" (BGNH) clinical cohort, with additional ELISA assays for lipopolysaccharide binding protein (LBP), IL-10, cortisol, and ACTH, signatures of immune-inflammatory response and Hypothalamic-Pituitary-Adrenal (HPA) axis activity, respectively. BGNH cohort includes healthy and overweight individuals diagnosed with IBS diarrhea-(IBS-D) and constipation-predominant (IBS-C) subtypes. We identified several potentially significant markers for IBS-D and IBS-C, notably IL-10, mean platelet volume (MPV), with LBP and monocyte percent also showing some statistical significance. Weight also showed significant results for overweight vs. normal weight, regardless of IBS subtype, particularly for Cortisol. CBC-D predictive profiles for IBS subtype and weight were identified using discriminant functions analysis and show that predictivity of marker profiles have poor performance relative to their normal weight subsets. Further refinement of this analysis will be performed utilizing increased sample size, additional molecular profiles, and enhanced statistical analysis.ACTHadrenocorticotropic hormoneBGNHBrain-Gut Natural History protocolBTRISBiomedical Translational Research Information SystemCAPchronic abdominal painCBC-Dcomplete blood count with differentialCRISClinical Research Information SystemCRPc-reactive proteinESRerythrocyte sedimentation rateHChealthy controlHCThematocritIBSirritable bowel syndromeIBS-Cirritable bowel syndrome, constipation-predominantIBS-Dirritable bowel syndrome, diarrhea-predominantIL-10interleukin-10LBPlipopolysaccharide binding proteinLDHlactate dehydrogenaseMCHmean corpuscular hemoglobinMPVmean platelet volumeNWnormal weightOWoverweightPBMCperipheral blood mononuclear cellsWBCwhite blood cell ER -